Smith Graham & Co Investment Advisors’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $9.63M | Sell |
760,858
-4,584
| -0.6% | -$57.8K | 1.11% | 20 |
|
|
2023
Q3 | $10.4M | Sell |
765,442
-7,240
| -0.9% | -$112K | 1.3% | 8 |
|
|
2023
Q2 | $13.3M | Sell |
772,682
-34,452
| -4% | -$534K | 1.6% | 4 |
|
|
2023
Q1 | $11.2M | Sell |
807,134
-2,542
| -0.3% | -$37.4K | 1.37% | 9 |
|
|
2022
Q4 | $10.8M | Sell |
809,676
-2,801
| -0.3% | -$36.2K | 1.33% | 9 |
|
|
2022
Q3 | $9.67M | Sell |
812,477
-1,134
| -0.1% | -$16.1K | 1.29% | 11 |
|
|
2022
Q2 | $10.4M | Sell |
813,611
-8,122
| -1% | -$104K | 1.28% | 8 |
|
|
2022
Q1 | $10.6M | Sell |
821,733
-5,364
| -0.6% | -$70.8K | 1.1% | 16 |
|
|
2021
Q4 | $13.1M | Sell |
827,097
-67,011
| -7% | -$1.14M | 1.3% | 14 |
|
|
2021
Q3 | $17.4M | Sell |
894,108
-77,109
| -8% | -$1.53M | 1.75% | 2 |
|
|
2021
Q2 | $22.1M | Sell |
971,217
-212,475
| -18% | -$4.41M | 1.95% | 1 |
|
|
2021
Q1 | $21.7M | Sell |
1,183,692
-51,580
| -4% | -$846K | 1.77% | 6 |
|
|
2020
Q4 | $18.4M | Sell |
1,235,272
-22,612
| -2% | -$295K | 1.69% | 3 |
|
|
2020
Q3 | $14.1M | Sell |
1,257,884
-19,038
| -1% | -$187K | 1.61% | 7 |
|
|
2020
Q2 | $10.1M | Buy |
1,276,922
+130,085
| +11% | +$1.08M | 1.23% | 19 |
|
|
2020
Q1 | $9.27M | Sell |
1,146,837
-114,553
| -9% | -$1.36M | 1.45% | 8 |
|
|
2019
Q4 | $15.9M | Sell |
1,261,390
-33,723
| -3% | -$363K | 1.55% | 1 |
|
|
2019
Q3 | $11.6M | Buy |
1,295,113
+7,313
| +0.6% | +$63.9K | 1.23% | 8 |
|
|
2019
Q2 | $11M | Buy |
1,287,800
+95,175
| +8% | +$752K | 1.19% | 12 |
|
|
2019
Q1 | $9.05M | Buy |
1,192,625
+284,731
| +31% | +$2.29M | 0.99% | 21 |
|
|
2018
Q4 | $7.51M | Sell |
907,894
-46,957
| -5% | -$449K | 0.92% | 30 |
|
|
2018
Q3 | $9.47M | Sell |
954,851
-94,711
| -9% | -$981K | 0.9% | 36 |
|
|
2018
Q2 | $10.3M | Sell |
1,049,562
-3,657
| -0.3% | -$35.9K | 0.97% | 23 |
|
|
2018
Q1 | $9.79M | Sell |
1,053,219
-21,084
| -2% | -$201K | 0.94% | 25 |
|
|
2017
Q4 | $10.2M | Sell |
1,074,303
-172,218
| -14% | -$1.65M | 0.96% | 27 |
|
|
2017
Q3 | $12.9M | Sell |
1,246,521
-12,807
| -1% | -$118K | 1.35% | 11 |
|
|
2017
Q2 | $10.4M | Sell |
1,259,328
-68,709
| -5% | -$516K | 1.13% | 17 |
|
|
2017
Q1 | $9.55M | Sell |
1,328,037
-25,167
| -2% | -$182K | 1.02% | 25 |
|
|
2016
Q4 | $9.66M | Buy |
1,353,204
+129,716
| +11% | +$903K | 1.05% | 29 |
|
|
2016
Q3 | $8.9M | Buy |
1,223,488
+35,468
| +3% | +$225K | 1.13% | 14 |
|
|
2016
Q2 | $6.96M | Sell |
1,188,020
-79,084
| -6% | -$524K | 0.96% | 25 |
|
|
2016
Q1 | $8.06M | Buy |
1,267,104
+44,284
| +4% | +$238K | 1.05% | 20 |
|
|
2015
Q4 | $7.85M | Buy |
1,222,820
+93,490
| +8% | +$584K | 1.11% | 18 |
|
|
2015
Q3 | $6.57M | Sell |
1,129,330
-3,229
| -0.3% | -$23.9K | 0.96% | 32 |
|
|
2015
Q2 | $9.88M | Sell |
1,132,559
-12,491
| -1% | -$105K | 1.33% | 12 |
|
|
2015
Q1 | $9.15M | Sell |
1,145,050
-1,392
| -0.1% | -$10.4K | 1.24% | 15 |
|
|
2014
Q4 | $8.89M | Sell |
1,146,442
-70,379
| -6% | -$513K | 1.27% | 13 |
|
|
2014
Q3 | $7.89M | Buy |
1,216,821
+55,865
| +5% | +$431K | 1.16% | 15 |
|
|
2014
Q2 | $9.76M | Sell |
1,160,956
-46,975
| -4% | -$364K | 1.36% | 13 |
|
|
2014
Q1 | $8.1M | Sell |
1,207,931
-84,077
| -7% | -$510K | 1.17% | 25 |
|
|
2013
Q4 | $8.08M | Buy |
1,292,008
+1,118,628
| +645% | +$5.46M | 1.14% | 28 |
|
|
2013
Q3 | $754K | Buy |
+173,380
| New | +$792K | 0.11% | 134 |
|
Other funds holding SEM
CCM
Smith Graham & Co Investment Advisors's SEM Position: Q4 2023 in Review
Smith Graham & Co Investment Advisors reduced its Select Medical (SEM) stake by 0.6% in Q4 2023, selling an estimated $57.8K and leaving 760,858 shares worth $9.63M. The position accounts for 1.11% of the portfolio, ranked #20.
Smith Graham & Co Investment Advisors first reported a position in SEM in Q3 2013 and has held it in 42 quarters since. The position peaked at $22.1M in Q2 2021. 248 funds tracked by Wall St. Rank hold SEM as of Q4 2023.
- Smith Graham & Co Investment Advisors held 760,858 shares of Select Medical worth $9.63M as of Q4 2023.
- Smith Graham & Co Investment Advisors sold 4,584 Select Medical shares in Q4 2023, an estimated $57.8K.
- Select Medical made up 1.11% of Smith Graham & Co Investment Advisors's portfolio in Q4 2023, its #20 holding.
- Smith Graham & Co Investment Advisors first reported a position in Select Medical in Q3 2013 and has held it in 42 quarters since.
- Smith Graham & Co Investment Advisors's Select Medical position peaked at $22.1M in Q2 2021.
- 248 funds tracked by Wall St. Rank held Select Medical as of Q4 2023.
Based on Smith Graham & Co Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.